Payden Equity Income Fund Adviser Cl
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PYVAX research report →
Companywww.payden.com/us-funds/pyvax
The investment seeks growth of capital and some current income. The fund invests primarily in large capitalization value stocks, defined as stocks with above average dividend yields and large market capitalizations, and other income producing equity securities, including by way of example, preferred stocks, real estate investment trusts and master limited partnerships. It invests principally in U.
- IPO
- 2011
- HQ
- Los Angeles, CA, US
Price Chart
Valuation
- Market Cap
- $1.29B
- P/E
- 0.00
- P/S
- 140.59
- P/B
- 0.00
- EV/EBITDA
- 11.82
- Div Yield
- 5.83%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- 23.83%
- Net Margin
- 1213.69%
- ROE
- 18.38%
- ROIC
- 0.34%
Growth & Income
- Revenue
- $9.20M · -12.34%
- Net Income
- $111.63M · 209.99%
- EPS
- $2.77 · 209.49%
- Op Income
- $2.19M
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $18.36
- 52W Low
- $15.94
- 50D MA
- $17.55
- 200D MA
- $17.42
- Beta
- 0.82
- Avg Volume
- 0
Get TickerSpark's AI analysis on PYVAX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PYVAX Coverage
We haven't published any research on PYVAX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PYVAX Report →